Evidence map›Paper›PMID 38413932›Full record

ArticleBMC pulmonary medicine2024

Artificial intelligence-based model for predicting pulmonary arterial hypertension on chest x-ray images.

Shun Imai, Seiichiro Sakao, Jun Nagata, Akira Naito, Ayumi Sekine, Toshihiko Sugiura, Ayako Shigeta, Akira Nishiyama, Hajime Yokota, Norihiro Shimizu and 7 more

Abstract read
In one paragraph

Article in BMC pulmonary medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Review
  8. Artificial intelligence enhanced contemporary pulmonary hypertension care.American heart journal plus : cardiology research and practice · 2025
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shun ImaiDepartment of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan. imashun9168@gmail.com.
Seiichiro SakaoDepartment of Pulmonary Medicine, School of Medicine, International University of Health and Welfare (IUHW), Chiba, Japan.
Jun NagataDepartment of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Akira NaitoDepartment of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Ayumi SekineDepartment of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Toshihiko SugiuraDepartment of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Ayako ShigetaDepartment of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Akira NishiyamaDepartment of Radiology, Tsudanuma Central General Hospital, Chiba, Japan.
Hajime YokotaDiagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Norihiro ShimizuMaebara Shimizu Eye Clinic, Chiba, Japan.
Takeshi SugawaraChiba University Hospital Translational Research and Development Center, Chiba, Japan.
Toshiaki NomiM3 Inc., Tokyo, Japan.
Seiwa HondaM3 Inc., Tokyo, Japan.
Keisuke OgakiM3 Inc., Tokyo, Japan.
Nobuhiro TanabePulmonary Hypertension Center, Chibaken Saiseikai Narashino Hospital, Chiba, Japan.
Takayuki BabaDepartment of Ophthalmology and Visual Science, Graduate School of Medicine, Chiba University, Chiba, Japan.
Takuji SuzukiDepartment of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPulmonary arterial hypertension is a serious medical condition. However, the condition is often misdiagnosed or a rather long delay occurs from symptom onset to diagnosis, associated with decreased 5-year survival. In this study, we developed and tested a deep-learning algorithm to detect pulmonary arterial hypertension using chest X-ray (CXR) images.

methodsFrom the image archive of Chiba University Hospital, 259 CXR images from 145 patients with pulmonary arterial hypertension and 260 CXR images from 260 control patients were identified; of which 418 were used for training and 101 were used for testing. Using the testing dataset for each image, the algorithm outputted a numerical value from 0 to 1 (the probability of the pulmonary arterial hypertension score). The training process employed a binary cross-entropy loss function with stochastic gradient descent optimization (learning rate parameter, α = 0.01). In addition, using the same testing dataset, the algorithm's ability to identify pulmonary arterial hypertension was compared with that of experienced doctors.

resultsThe area under the curve (AUC) of the receiver operating characteristic curve for the detection ability of the algorithm was 0.988. Using an AUC threshold of 0.69, the sensitivity and specificity of the algorithm were 0.933 and 0.982, respectively. The AUC of the algorithm's detection ability was superior to that of the doctors.

conclusionThe CXR image-derived deep-learning algorithm had superior pulmonary arterial hypertension detection capability compared with that of experienced doctors.

Indexed as

Deep LearningPulmonary Arterial HypertensionArtificial IntelligenceHumansThoraxX-RaysArtificial intelligenceChest X-rayDeep learningPulmonary arterial hypertension

Identifiers

PMID38413932
PMCPMC10898025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.